Kathy Shair

8PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)BiomaterialsEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 27, 2026
An Epstein-Barr Virus Nuclear Antigen 1 (EBNA1) Serology Test Strip for Nasopharyngeal Carcinoma Risk Screening.

|Sep 09, 2025
Model Systems of Gammaherpesvirus Infection, Immunity, and Disease.

Arundhati Gupta, Renfeng Li, Kathy Shair

|May 23, 2025
Disruption of ATR Signaling by Epstein-Barr Virus Latent Membrane Protein 1 Sensitizes Nasopharyngeal Carcinoma Cells to Cisplatin.

Gabriella Zarkovic, Phillip Ziegler, Jennifer Hye-Rim Lee

|Sep 12, 2024
The Epstein-Barr Virus Nuclear Antigen 1 Variant Associated with Nasopharyngeal Carcinoma Defines the Sequence Criteria for Serologic Risk Prediction.

Benjamin E Warner, Japan Patel, Renwei Wang

|Sep 27, 2022
Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma.

Sarita Paudel, Benjamin E Warner, Renwei Wang

|Apr 29, 2021
A primary nasopharyngeal three-dimensional air-liquid interface cell culture model of the pseudostratified epithelium reveals differential donor- and cell type-specific susceptibility to Epstein-Barr virus infection.

Phillip Ziegler, Yarong Tian, Yulong Bai

Pageof 2

Frequent Collaborators

3 joint publications

Alan Bäckerholm

3 joint publications

Jian-Min Yuan

3 joint publications

Woon-Puay Koh

3 joint publications

Benjamin E Warner